Science Daily - Heart Disease
JUNE 10, 2024
After women go through menopause, their risk of heart disease increases dramatically. Researchers studied whether beetroot juice, which is rich in nitrate, can improve how blood vessels function. The results showed that daily consumption of beetroot juice by postmenopausal women may improve blood vessel function enough to reduce future heart disease risk.
HCPLive
JUNE 10, 2024
The accelerated approval is based on data from the phase 3 ELATIVE trial demonstrating a reduction in alkaline phosphatase with elafibranor.
Science Daily - Heart Disease
JUNE 10, 2024
New research discovers a potential path to prevent permanent scarring and heart failure following a myocardial infarction.
HCPLive
JUNE 10, 2024
Study from RAD 2024 finds 36% higher risk of nonmelanoma skin cancer in patients with atopic dermatitis relative to matched controls.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Science Daily - Heart Disease
JUNE 10, 2024
A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis, a condition referred to as the 'Alzheimer's disease of the heart.' As the first amyloid-specific and pan-amyloid binding radiotracer designed for planar and SPECT/CT imaging, 99mTc-p5+14 could play an important role in early detection and treatment of cardiac amyloidosis.
DAIC
JUNE 10, 2024
milla1cf Mon, 06/10/2024 - 17:58 June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial tricuspid clip procedure in the Carolinas, performed in May at Atrium Health Carolinas Medical Center. This achievement marks a significant milestone in the treatment of tricuspid regurgitation (TR), offering new hope to patients who are not candidates for traditional open-heart surgery.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Med Page Today
JUNE 10, 2024
(MedPage Today) -- The FDA expanded the approval of GSK's respiratory syncytial virus (RSV) vaccine (Arexvy) to include adults ages 50 to 59 at risk of RSV-related lower respiratory tract disease (LRTD) due to underlying conditions, the company.
Science Daily - Heart Disease
JUNE 10, 2024
Abnormal blood flow in the aorta is linked to inflammation and breakdown of the vessel wall in conditions where the aorta is dilated. The findings can contribute to better diagnosis and open up new ways to assess the risk of serious and usually fatal complications, such as rupture of the aorta.
DAIC
JUNE 10, 2024
Getty Images milla1cf Mon, 06/10/2024 - 18:02 June 10, 2024 — New expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) reviews previously published qualitative and semi-quantitative measurements – including clinical guidelines like CAD-RADS 2.0 and disease classification scores such as the CT SYNTAX score for coronary revascularization – to create a comprehensive synopsis concerning quantitative CCTA methods.
Science Daily - Heart Disease
JUNE 10, 2024
If national guidelines are revised to incorporate a new risk equation, about 40% fewer people could meet criteria for cholesterol-lowering statins to prevent heart disease. The study examines the potential impact of widespread adoption of the PREVENT equations, which were released by the American Heart Association in November 2023 to update physicians' go-to calculators for assessing patients' 10-year risk of heart attack or stroke.
Cassling
JUNE 10, 2024
From Field Service Engineer (FSE) to Account Executive (AE), Jay Tolsma’s role has evolved over his 20-year career with Cassling, but what hasn’t changed is Jay’s dedication to the job and his colleagues.
HCPLive
JUNE 10, 2024
Strnad explains key findings from research presented at the EASL Congress regarding noninvasive testing and biomarkers in AATD-LD based on phase 2 fazirsiran clinical trials.
Medical Xpress - Cardiology
JUNE 10, 2024
A new study by investigators at Massachusetts General Hospital (MGH) reveals an important step to help the human heart regenerate after myocardial infarction (MI).
HCPLive
JUNE 10, 2024
Grandner highlights the importance of focusing on insomnia treatment for sleep-related anxiety—not anxiety treatment.
Becker's Hospital Review - Cardiology
JUNE 10, 2024
Charlotte, N.C.-based Atrium Health Sanger Heart & Vascular Institute is among the first institutions in the Carolinas to treat coronary artery disease using a newly FDA-approved device made by Boston Scientific.
HCPLive
JUNE 10, 2024
Lisa Swanson, MD, discusses the pathogenesis of atopic dermatitis and why she does not recommend elimination diets for her pediatric patients.
Medical Xpress - Cardiology
JUNE 10, 2024
A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis, a condition referred to as the "Alzheimer's disease of the heart." As the first amyloid-specific and pan-amyloid binding radiotracer designed for planar and SPECT/CT imaging, 99mTc-p5+14 could play an important role in early detection and treatment of cardiac amyloidosis.
HCPLive
JUNE 10, 2024
Jonathan Silverberg, MD, PhD, MPH, discusses how the results of the LEVEL UP trial impact treatment decisions for patients with moderate-to-severe atopic dermatitis.
Medical Xpress - Cardiology
JUNE 10, 2024
A new blood test that could identify children with a potentially fatal heart condition has been developed by researchers at UCL and Great Ormond Street Hospital (GOSH).
HCPLive
JUNE 10, 2024
Treating eczema twice-daily with ruxolitinib cream, 1.5% led to positive results for children in the age range of 2 to 11 years.
American College of Cardiology
JUNE 10, 2024
"Comprehensive strategies to mitigate pollution and climate change are paramount to protect the environment and safeguard human health globally," say leading global experts as part of a two-part JACC Focus Seminar on pollution and cardiovascular disease.
HCPLive
JUNE 10, 2024
Patients with HS are getting a long-awaited influx of targeted therapies. Jennifer L. Hsiao, MD, discusses their immediate impact.
American College of Cardiology
JUNE 10, 2024
Pulsed field ablation (PFA) was shown to be effective in treating patients with paroxysmal atrial fibrillation (AFib), with more patients free from atrial arrhythmias (AA) when compared with patients treated with thermal ablation, according to results from a secondary analysis of the ADVENT trial. The results of the single-blind study were presented at Heart Rhythm 2024 and simultaneously published in JACC.
HCPLive
JUNE 10, 2024
Silvio Danese, MD, PhD; Bruce Sands, MD, and Jean-Frederic Colombel, MD, discuss their preferred recommended targets for managing ulcerative colitis (UC) or Crohn's disease (CD), emphasizing the aggressive approach required to achieve these targets effectively.
American College of Cardiology
JUNE 10, 2024
What is the comparative effectiveness of therapies targeting the different treatment pathways in pulmonary arterial hypertension (PAH)?
HCPLive
JUNE 10, 2024
Matthew Zirwas, MD, provides advice to dermatologists discussing the safety of JAK inhibitor therapies due to their controversial black box warning.
American College of Cardiology
JUNE 10, 2024
What is the safety, tolerability, and efficacy of high-intensity care (HIC) following hospital discharge for acute heart failure (HF) based on estimated clinical risk scores?
HCPLive
JUNE 10, 2024
In this open-label extension trial presented at RAD 2024, the long-term safety and efficacy results of roflumilast cream in adults and children with eczema was highlighted.
Med Page Today
JUNE 10, 2024
(MedPage Today) -- NEW YORK CITY -- With valve-in-valve procedures becoming a key concern for patients with aortic stenosis, familiar transcatheter aortic valve replacement (TAVR) devices are being tweaked to facilitate future operations that.
HCPLive
JUNE 10, 2024
At SLEEP 2024, Badr presented on novel treatments for central sleep apnea like phrenic nerve stimulation.
American College of Cardiology
JUNE 10, 2024
Splanchnic ablation for volume management (SAVM) in heart failure with preserved ejection fraction (HFpEF) was discussed as a late-breaking trial at the Heart Failure Society of America (HFSA) Annual Scientific Meeting 2023 in Cleveland, Ohio.
HCPLive
JUNE 10, 2024
Rosmarin discussed several treatments in development covered in his RAD 2024 presentation for the treatment of patients with eczema.
HeartRhythm
JUNE 10, 2024
Patent foramen ovale (PFO) affects 20%–34% of adults and is associated with strokes and other disorders. The conventional treatment of PFO-related strokes is a closure procedure. The metal device is associated with some adverse events.
HCPLive
JUNE 10, 2024
The new approval expands the treatment area by 4 times the previously approved area—from 25 cm2 to 100 cm2.
Coronary Artery Disease Journal
JUNE 10, 2024
Background Despite improvements in outcomes of ST elevation myocardial infarction (STEMI), ventricular septal rupture (VSR) remains a known complication, carrying high mortality. The contemporary incidence, mortality, and management of post-STEMI VSR remains unclear. Methods The National Inpatient Sample database (2009–2020) was used to study trends in admissions and outcomes of post-STEMI VSR over time.
HCPLive
JUNE 10, 2024
An analysis of data from the LIBERTY AD trial presented at RAD 2024 details the risk of infections observed with dupilumab use with up to 5 years of follow-up.
Expert insights. Personalized for you.
118 
Let's personalize your content